China Pharma Holdings (CPHI) Current Deferred Tax Assets (2010 - 2013)
China Pharma Holdings' (CPHI) quarterly Current Deferred Tax Assets came in at $2.2 million in Q3 2013, up 223.62% YoY from $678297.0 in Q3 2012, and up 29.88% on a QoQ basis from $1.7 million in Q2 2013.
China Pharma Holdings (CPHI) Current Deferred Tax Assets (2010 - 2013) Analysis & Trends
China Pharma Holdings (CPHI) has 4 years of Current Deferred Tax Assets data on file, last reported at $2.2 million in Q3 2013.
- Quarterly Current Deferred Tax Assets rose 223.62% year-over-year to $2.2 million in Q3 2013, while the trailing twelve-month figure through Sep 2013 was $2.2 million (up 223.62% YoY) and the FY2012 annual result came in at $967671.0, up 70.9% from the prior year.
- Current Deferred Tax Assets improved to $2.2 million in Q3 2013, from $1.7 million in the prior quarter.
- In the past five years, Current Deferred Tax Assets ranged from a high of $2.2 million in Q3 2013 to a low of $518906.0 in Q3 2011.
- A 4-year average of $899573.5 and a median of $653266.0 in 2012 frame the typical range for Current Deferred Tax Assets.
- Annual changes were most pronounced in 2011 — Current Deferred Tax Assets grew 7.1% — and 2013, when it jumped 223.62%.
- Tracing CPHI's Current Deferred Tax Assets over 4 years: stood at $528684.0 in 2010, then advanced by 7.1% to $566226.0 in 2011, then soared by 70.9% to $967671.0 in 2012, then soared by 126.85% to $2.2 million in 2013.
- The last three Current Deferred Tax Assets figures came in at $2.2 million (Q3 2013), $1.7 million (Q2 2013), and $954980.0 (Q1 2013), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | China Pharma Holdings | 42.14 Mn | 41.84 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2013 | 2.20 Mn |
| Sep 30, 2013 | 2.20 Mn |
| Jun 30, 2013 | 1.69 Mn |
| Jun 30, 2013 | 1.69 Mn |
| Mar 31, 2013 | 954,980.00 |
| Mar 31, 2013 | 954,980.00 |
| Dec 31, 2012 | 967,671.00 |
| Dec 31, 2012 | 967,671.00 |
| Sep 30, 2012 | 678,297.00 |
| Sep 30, 2012 | 678,297.00 |
| Jun 30, 2012 | 653,266.00 |
| Jun 30, 2012 | 653,266.00 |
| Mar 31, 2012 | 617,753.00 |
| Mar 31, 2012 | 617,753.00 |
| Dec 31, 2011 | 566,226.00 |
| Dec 31, 2011 | 566,226.00 |
| Sep 30, 2011 | 518,906.00 |
| Sep 30, 2011 | 518,906.00 |
| Jun 30, 2011 | 524,290.00 |
| Jun 30, 2011 | 524,290.00 |